The end of the Obama administration could prompt a rush to wrap up health-care fraud investigations and settlements at the DOJ, according to several former agency attorneys.

The start of a new presidential administration on Jan. 20, 2017, means that U.S. attorneys in the 93 districts around the country will be replaced by new appointees, whether either Hillary Clinton or Donald Trump win the presidential contest in November.

I spoke with several former Department of Justice attorneys about their experiences with the presidential transition period in U.S. attorney’s offices, and how it might affect health-care fraud investigations and False Claims Act lawsuits.

Although each former DOJ prosecutor stressed that “continuity” and professionalism ruled the day when it came to handing investigations over to an incoming U.S. attorney, they described certain opportunities that may arise for parties involved in health-care fraud litigation.

Laurence J. Freedman with Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC in Washington said there typically is an “administration end rush to get things wrapped up that are of significant importance to a U.S. attorney.”

Read the full article here, and learn what else Freedman, and other former DOJ attorneys have to say about what health-care attorneys should watch for if a new U.S. attorney comes to your district office, and how the end of the administration might affect your negotiations with the DOJ.

Learn more about Bloomberg Law and sign up for a free trial.

Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.